United States · FDA National Drug Code directory

Rizatriptan Benzoate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2536_9fd5b7a4-8fbb-417f-9deb-b692d7db3cb9
Product NDC
71335-2536
Form
TABLET
Composition / generic term
Rizatriptan Benzoate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20121231
Source listing expiry
20261231

Source-listed ingredients

  • RIZATRIPTAN BENZOATE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BLISTER PACK (71335-2536-1) · 71335-2536-1
  • 18 TABLET in 1 BLISTER PACK (71335-2536-2) · 71335-2536-2
  • 12 TABLET in 1 BLISTER PACK (71335-2536-3) · 71335-2536-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →